Pulmonary vascular resistance at baseline and after long-term infusion of epoprostenol

The patients underwent right heart catheterization at the points cited and pulmonary vascular resistance was calculated.

PVR: pulmonary vascular resistance.
* p <0.05 compared with PVR at baseline.
• p <0.05 compared with PVR after acute infusion of epoprostenol. There were not enough patients at 24 months to determine significance.

Reproduced with permission from: Aguilar, RV, Farber, HW. Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension. Am J Respir Crit Care Med 2000; 162:1846. Copyright ©2000 American Thoracic Society.

Graphic 64309 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟